• Home
  • NEW DAY MEDICINE
  • 11 (73) 2024
  • 40 -11 (72) 2024 - Nurov J.R., Кhurshidova M.J. - DEVELOPMENT OF SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX ASSOCIATED WITH HUMAN PAPILLOMAVIRUS

40 -11 (72) 2024 - Nurov J.R., Кhurshidova M.J. - DEVELOPMENT OF SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX ASSOCIATED WITH HUMAN PAPILLOMAVIRUS

DEVELOPMENT OF SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX ASSOCIATED WITH HUMAN PAPILLOMAVIRUS

Nurov J.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Кhurshidova M.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Squamous cell carcinoma associated with HPV is a type of oropharyngeal cancer. Since the early 1980s, scientists began to discuss the role of the human papillomavirus in the development of HNSCC, mainly laryngeal cancer. However, in recent years, more attention has been paid to the risk of developing malignant tumors of the oropharynx against the background of HPV infection. The frequency of HPV detection in tumors of this localization varies from 20 to 60%. The occurrence of oropharyngeal squamous cell carcinoma (OSCC) is traditionally associated with exposure to tobacco smoke and alcohol. However, in the last 30 years, despite a decrease in the prevalence of smoking, there has been a stabilization and subsequent increase in the incidence of ORSCCC. This increase in the incidence of OFCC is currently associated with human papillomavirus infection.

Keywords: oropharyngeal squamous cell carcinoma, human papillomavirus, HPV-positive OFCC

First page

214

Last page

216/p>

For citation:Nurov J.R., Кhurshidova M.J. - DEVELOPMENT OF SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX ASSOCIATED WITH HUMAN PAPILLOMAVIRUS//New Day in Medicine 11(73)2024 214-216 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30. doi:10.3322/caac.21590
  2. HPV and other infectious agents in cancer: opportunities for prevention and public health / Eds H. Krueger et al. — New York: Oxford University Press, 2010.
  3. Rintala M., Grenman S., Puranen M. et al. | J. Clin. Virol. — 2006. - Vol. 35, N 1. P. 89-94.
  4. Zur Hausen H. Infections causing human cancer.Heidelberg: Wiley-VCH, 2006.
  5. Shanthi M. // Lancet Oncol. — 2010. — Vol. 11. — P. 781—789.16:14
  6. Kreimer A. R., Clifford G. M., Boyle P., Franceschi S. // Cancer Epidemiol. Biomarkers Prev. — 2005. — Vol. 14. — P. 467—475.16:15
  7. Мудунов А. М. Вирус папилломы человека - новый этиологический фактор в развитии рака органов головы и шеи. Проблемы и перспективы их решения. Эпидемиология и Вакцинопрофилактика. 2018; 17 (5): 100-105| DOI: 10.31631/2073-3046-2018-17-5-100-105
  8. International Agency for Research on Cancer. Monographs on the evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses.-Lyon, France, World, Health Organisation,2007. – P. 670.
  9. Best S.R., Niparko K.J., Pai S.I. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers // Otolaryngol. Clin. North Am. 2012.
  10. Mandal R., Senbabaoglu Y., Desrichard A. et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight 2016;1(17): c89829. DOI: 10.1172/jci.insight.89829.
  11. Oguejiofor K., Hall J., Slater C. et al. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamouscarcinoma. Br J Cancer 2015;113(6):886-93. DOl: 10.1038/bjc.2015.277.
  12. Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015:517(7536):576—82.1 DOI: 10.1038/nature14129.
  13. Lydiatt W. M., Patel S. G., O'Sullivan B. et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual // CA Cancer J Clin. — 2017. — Nº 2. — P. 122-137.

    file

    download